US Follows WHO: Monkeypox Is a Public Health Emergency
The declaration will allow more funds for control of and resources for the disease.
Monkeypox (Adobe Stock)
This article was originally published in Contagionlive.com.
US Health Secretary Xavier Becerra declared a national public health emergency for monkeypox.
“In light of evolving circumstances on the ground, I am declaring a public health emergency on #monkeypox. We are prepared to take our response to the next level in addressing this virus. We urge every American to take monkeypox seriously," Becerra, tweeted on August 4.
The declaration mobilizes the response and opens up federal funding to address the virus.
As of yesterday, there has been 6617 confirmed cases with California and New York having the most cases. Earlier this week, California Governor Gavin Newsom declared a state of emergency with regards to the monkeypox outbreak. This came on the heels of San Francisco and New York City declaring states of emergency along with New York State’s declaration that monkeypox is an "imminent threat to public health," over the last week. Shortly before that, World Health Organization declared monkeypox a “global health emergency.”
The US federal agencies are making vaccines and treatment available. For example, CDC and FDA have developed a process to help clinicians secure an antiviral therapy, tecovirimat (Tpoxx), for treatment for patients with monkeypox. This falls under the expanded access investigational new drug (EA-IND). Clinicians can begin the process to secure tecovirimat by going here.
Tecovirimat is manufactured by SIGA Technologies, and is approved for smallpox and is being studied for monkeypox treatment. Infection Control Today®’s (ICT®’s) sister publication, Contagion Live, spoke with SIGA Technologies Chief Scientific Officer Dennis Hruby, PhD, recently about the therapy.
The federal government has also been sending out vaccines to prevent the spread of monkeypox. At this point in time, it has been reported that only people who are close personal contacts of people who have contracted the virus are eligible to get access to the vaccines.
ICT® gives details about monkeypox, what it is and how it is spread, here.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
